Janus Henderson Group PLC Reduces Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Janus Henderson Group PLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 833,916 shares of the company's stock after selling 65,324 shares during the period. Janus Henderson Group PLC owned approximately 0.96% of HealthEquity worth $80,016,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity in the fourth quarter valued at approximately $26,000. Transce3nd LLC purchased a new stake in HealthEquity in the 4th quarter valued at approximately $29,000. Smartleaf Asset Management LLC lifted its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares in the last quarter. Proficio Capital Partners LLC acquired a new stake in HealthEquity during the 4th quarter valued at $39,000. Finally, UMB Bank n.a. increased its position in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. The trade was a 6.34% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HQY has been the topic of several recent research reports. The Goldman Sachs Group reduced their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price objective for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, KeyCorp lowered their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $111.75.

HealthEquity Trading Up 0.6%

Shares of NASDAQ HQY traded up $0.58 during trading on Friday, hitting $98.23. 815,837 shares of the company traded hands, compared to its average volume of 793,557. The firm has a market capitalization of $8.50 billion, a P/E ratio of 90.12, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average price of $87.83 and a 200-day moving average price of $96.89. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.